Werner Dobrowsky
Newcastle upon Tyne Hospitals NHS Foundation Trust · 93 works · 3,647 citations · h-index 24
Top works
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
- Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers
- Histologic tumor regression grades in squamous cell carcinoma of the head and neck after preoperative radiochemotherapy
- Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
- Conventional vs modified fractionated radiotherapy. meta-analysis of radiotherapy in head & neck squamous cell carcinoma : a meta-analysis based on individual patient data
- Radiotherapy of presacral recurrence following radical surgery for rectal carcinoma
- Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer
- The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis
- Combined radiation therapy, mitomycin C, and 5-fluorouracil for locally recurrent rectal carcinoma: Results of a pilot study
- Mode of interaction of 5-fluorouracil, radiation, and mitomycin C: In vitro studies
- Hyperfractionated or accelerated radiotherapy for head and neck cancer
- Treatment of choroid metastases
- Palliative radiotherapy for locally advanced non-metastatic head and neck cancer: A systematic review
- [Incidence of osteoradionecrosis after combined radiotherapy-chemotherapy of head and neck tumors].
- Response to preoperative concomitant radiochemotherapy with mitomycin C and 5-fluorouracil in advanced head and neck cancer
- Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)
- Combined modality treatment of advanced cancers of the oral cavity and oropharynx
- Priorities for the Head and Neck Cancer Patient, their Companion and Members of the Multidisciplinary Team and Decision Regret
- AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: Results of an IAEA multicentre randomised trial